Nevyas Eye Associates
Before The Nevyases Study PDF Print E-mail

It started with Ed Sullivan, the guy who built the 'Nevyas Laser', a man already under scrutiny by the FDA...

"Ed Sullivan, doing business as ExSull, Drexel Hill, Pa, has been put on notice by the FDA that the agency regards him "clearly as a manufacturer with multiple manufacturing sites" subject to FDA rules and regulations and, if he makes another one of these excimer lasers "which are unapproved devices," he will be in violation of the federal Food, Drug and Cosmetics Act and subject to legal penalties, according to top-ranking FDA officials within the national Division of Enforcement." [as written in The Journal of Refractive Surgery - Volume 11 (5) * September/October 1995 * News and can be found at the url address http://www.slackinc.com/eye/jrs/vol115/news1.htm]

And the FDA knew that! From the affidavit Herbert Nevyas submitted to the FDA, it tells of Ed Sullivan building their laser. However, documents show Mr. Sullivan in teleconferences and meetings with the doctors and their laison with the FDA well after this article was written.

After I received inspection reports even less redacted from the FDA regarding inspections of the Nevyas' facility, the FDA promised "to do what they could to help me", but then refused after copies of the inspection reports were returned. In fact Les Weinstein, the CDRH Ombudsman, outright told me (through his secretary) he could no longer have any communication with me. It seems to me (based on my communications with the FDA) that the FDA was more concerned with being sued by the Nevyases for the information released, then by doing the right thing.

The inspection reports of Sullivan's facility below were obtained via the Freedom Of Information Act.  Regardless of these reports and the articles written concerning 'Homegrown Lasers", is this what the FDA considers "protecting the public's safety"?

Click PAGE # to open pages in new window

PAGE 1 - Previous inspection, 5/16/96, was a follow up to a Warning Letter issued on 8/17/95. The Warning Letter informed the firm that the FDA considered ExSull, Inc., to be a manufacturer of a Class III medical device, that was both adulterated and misbranded, in that there were no approved PMA or IDE for any of the devices and that the firm itself was not registered as a medical device manufacturer.

PAGE 2 - Mr. Sullivan stated that "he called the FDA and was sent material relating to the building of "custom devices", and that the FDA person he had spoken to over the telephone assured him that it was okay to build them in the Doctor's office".

PAGE 3 - Repeated attempts to schedule a subsequent meeting with Mr. Sullivan (via my leaving numerous messages on his voice mail) were unsuccessful. Mr. Sullivan would not commit to a date and time, when he returned my repeated phone calls, and in some instances did not even return my phone calls. Only after inadvertently meeting him at one of his client's (on 6/25/97), did he then agree to see me at his ExSull, Inc.,

PAGE 4 - Mr. Sullivan stated that he did not have any standard procedures for assembling the device. He stated that the device components are delivered to each physician's office, where he then assembles the compete excimer laser. He informed me that he will then test the laser, but that he does not have any performance specifications, written assembly instructions or quality control tests.

PAGE 5 - and that any involvement by Mr. Sullivan in a sale, would depend on the nature of the sale. He would not elaborate on that statement, but explained that it means that he is not involved in every sale.

PAGE 6 - Mr. Sullivan informed me that he has not contracted to build any additional units, since he assembled the device for [redacted] in October 1996. On 6/26/97, Mr. Sullivan showed me a copy of an IDE for that same client [redacted], Mr. Sullivan explained that he was working on the document, and an examination of the IDE showed that the unit had been used to treat at least [redacted] patients, without an approved IDE. Mr. Sullivan would not allow me to copy this document, and stated that the FDA already has this IDE on file.

PAGE 7 - Mr. Sullivan did state that he will be publishing an article with a Dr. Herbert Nevyas, regarding the use of the ExSull, Inc., excimer laser for treatment of a patient with an irregular cornea, due to an eye injury.

PAGE 8 - According to Mr. Sullivan, this entire process (the exchange of laser beam requirements and the design specifications) is all done via telephone or personal visits, and he does not have any written records of the design specifications. He stated that each individual physician should have those records. Mr. Sullivan stated that he knew of no injuries with the device. He did say that in theory the laser would have some patients possibly experiencing overcorrection, but that the majority would experience a slight undercorrection, which might require additional treatment. In addition, he explained that there has been no hazing or scaring, with the devices. He stated that the physicians handle all of the complaints from the patients, and that he is not aware of any major complications.

PAGE 9 - Mr. Sullivan informed me that he designed the hardware for the "beam shaper" or "beam sculptor", as well as, the software that controls that hardware. He stated that his program was written in [redacted]  and that three versions have been made, of that software. He informed me that he had no documentation or procedures for upgrading or changing the program (at the  [redacted]. In addition, he could not provide any information regarding which of the software versions are in any of the particular devices, stating that he did not keep any of those records.

PAGE 10 - Mr. Sullivan gave his permission for me to observe the calibration procedure. I was allowed to examine the optical compartment, including the "beam shaper" or "beam sculptor", designed by Mr. Sullivan. Mr. Sullivan would not let me photograph this part of the device.

PAGE 11 - He informed me that he is only a consultant, and that each device he assembles is considered a "Custom Device". He confirmed that he did not have any medical device manufacturing records, such as Master Device Record or Device History Record. I asked Mr. Sullivan if the firm had a Device Master Record or Device History Record. He responded that he considers himself a consultant, and that he does not keep any records of design specifications, manufacturing specifications or a device History Record. He stated that each of the physicians might have any documentation for the specifications or design, for their device.

PAGE 12 - During the inspection, Mr. Sullivan stated that the firm's computer, used to store all of the business records, had experienced a "hard drive crash", in the winter of 1996. He explained that consequently all records from 1994 to December 1996 have been lost.

PAGE 13 - He stated that he does not keep any repair or service log books, or a records of any complaints regarding the performance of the laser, by the physicians.

PAGE 14 - There are no Exhibits with this EIR, due to the unavailability of records at the firm.

PAGE 15 - The observations noted in this FDA-4B3 are not an exhaustive listing of objectionable conditions. FDA 483 issued.

View ALL PAGES pdf document.

The FDA issued warning letters regarding the lasers Sullivan built, but STILL allowed doctors to further modify and use these devices on people considering LASIK!

Warning Letter 1 <>  Warning Letter 2

 
Nevyases Investigational Study PDF Print E-mail

The following letters are from the FDA to Drs. Herbert Nevyas and Anita Nevyas-Wallace throughout their investigational study, and after their study was terminated.

Click PAGE # to open page in new window

NOTES: Page numbers with an "l" designate the page as landscape. All BLUE font on this page designate links.

May 1997

IDE Disapproval Letter from the FDA to Nevyases dated 05/08/97:

PAGE 1 - The Food and Drug Administration (FDA) has reviewed your investigational device exemptions (IDE) application. We regret to inform you that your application is disapproved and you may not begin your investigation. Our disapproval is based on the deficiencies listed below.

PAGE 2 - Deficiencies listed.

PAGE 3 - Please explain the low effectiveness and safety outcomes achieved in your prior clinical studies and specify what steps you are taking to improve your results. Your refractive and visual outcomes were reported at one month as: MSRE for low myopes, < 57% were within ID and < 35% were within 0.5D; less than 60% achieved BUCVA > 20/40; complication and adverse events occurred in > 2% of the cases.

PAGE 4 - Please provide your agreement (or justification for not agreeing) that retreatments done to improve refractive outcome are NOT considered as treatment failures, whereas retreatments done to achieve resolution of an adverse event ARE considered as treatment failures.

PAGE 5 - Your description of study procedures, examination conditions and techniques is not adequate. Please provide a detailed description of each procedure, test and instrument to be used in the study.

PAGE 6 - For your follow-up visit schedule, the text on page 20 of the protocol appears to be inconsistent with the chart on page 43 of the protocol. In addition, please justify your statement on page 20 that measurement of corneal topography will be at the discretion of the investigator.

View ALL PAGES pdf document.

July 1997

Letter from the FDA to Nevyases dated 07/29/97 to cease using Laser:

PAGE 1 - FDA is aware that a number of physicians are using lasers for refractive surgery to treat patients even though there is no PMA or IDE in effect for their lasers. Based on the results of our investigations, we believe that you are currently using your laser to treat patients.

PAGE 2 - Accordingly, on July 28, 1997, we called you to notify you that use of your excimer laser to treat patients would violate the Act and requested that, if you are presently using the laser to treat patients, you immediately cease doing so.

Nevertheless, FDA does intend to consider any use of your laser to treat patients after the close of business July 28, 1997 unless and until the agency approves an IDE for your device to be grounds for disapproval of your IDE.

PAGE 3 - We also want you to know that if FDA approves your IDE application, you would be able to use your laser to perform only specific procedures on a limited number of subjects to demonstrate the safety and effectiveness of your laser for those procedures. Studies conducted under such an IDE would be subject to all IDE regulations. See 21 C.F.R. Part 812. For example, you would be prohibited from promoting and commercializing the laser, and from representing that the device is safe and effective.

View ALL PAGES pdf document.

August 1997

'Conditional' Approval Letter from the FDA to Nevyases dated 08/07/97:

PAGE 1 - Your application is conditionally approved because you have not adequately addressed deficiency #2 cited in our May 8, 1997 disapproval letter.

Also, we are in receipt of your certification (Amendment 4 received August 1, 1997) that you have not used the laser as of the close of business on July 28, 1997, and that you will not use the laser unless and until FDA approves the IDE applic2tion for your device

PAGE 2 - This approval is being granted on the condition that, within 45 days from the date of this letter, you submit information correcting the following deficiencies.

PAGE 3 - Deficiencies listed.

PAGE 4 - Deficiencies listed.

PAGE 5 - We have enclosed the guidance document entitled "Sponsor's Responsibilities for a Significant Risk Device Investigation" to help you understand the functions and duties of a sponsor.

View ALL PAGES pdf document.

October 1997

Letter from the FDA to Nevyases dated 10/03/97:

PAGE 1 - We acknowledge receipt of your institutional review board (IRB) approval (supplement 3). Supplement 4 responds to our conditional approval letter of August 7, 1997 and requests: an increase crease in treatment range from -6.75 ID to -22 ID; approval to study simultaneous bilateral treatment; and, approval to retreat approximately 125 patients previously treated with this laser prior to IDE approval.

PAGE 2 - Requests for additional subjects for enhancements for prior clinical patients will be evaluated as additional data is submitted to support stability of the procedure.

PAGE 3 - You agree that you will not perform retreatment procedures for subjects initially treated under this IDE. Retreatment (enhancement) for subjects initially treated under this IDE is appropriate only after your preliminary data demonstrate safety and indicate the time point of stability of the procedure. You may begin retreatment procedures only after FDA has approved your retreatment study plan and data to support stability.

PAGE 4 - PAGE 5 - PAGE 6 - PAGE 7 - PAGE 8 - PAGE 9 - PAGE 10 - Deficiencies listed.

PAGE 11

View ALL PAGES pdf document.

December 1997

Approval Review Letter from the FDA to Nevyases:

PAGE 1 - The Food and Drug Administration (FDA) has reviewed the supplement to your investigational device exemptions (IDE) application. Your application remains conditionally approved because your supplement adequately addressed only deficiency 2 cited in our October 3, 1997 letter.

This approval is being granted on the condition that, within 45 days from the date of this letter, you submit information correcting the following deficiencies.

PAGE 2 - You are reminded that prior to a request for expansion beyond 150 subjects, you should provide adequate responses to deficiencies 5 16 in our letter of October 3, 1997.

View ALL PAGES pdf document.

 

FDA INVESTIGATIONAL STUDY AFFIDAVIT

The following pages are an Investigator Agreement issued by the FDA to a Sponsor/Investigator of an investigational study.  Nevyas refused to sign...

PAGE 1 PAGE 2 PAGE 3 PAGE 4 PAGE 5 PAGE 6 ALL PAGES  

 

Nevyases were issued an FDA483:

PAGE 1 - There was no documentation to show that the CI notified the IRB about all amendments, changes of significant deviations to the protocol [per IRB requirements] prior to implementation. For example, the FDA granted your firm an increase in the number of subjects you could treat with your investigational device on Jan. 20, 1999. IRB. Annual Review dated 7/29/00 does not indicate the IRB knew about population increase. The IRB did not approve the population increase until. August 28, 2000, 20 months later.

The firm is not complying with the Investigator Agreement which was signed and dated by the Clinical Investigator at the beginning of the Clinical Study.

There was a lapse of IRB approval for the protocol: NEV-97-001 from 8/3/2000 until 8/29/2000 according to IRB, lapse notices and the IRB annual reapproval letter.

 

Nevyases' Co-Investigators

I started some time ago to contact the doctors on this LIST the Nevyases sent to the FDA, as being co-investigators. Three of those contacted who responded have never even heard of the Nevyases.

January 1998

Approval Review Letter from the FDA to Nevyases:

PAGE 1 PAGE 2 PAGE 3

April 1998

Letter from the FDA to Nevyases dated 04/01/98 Re: Pre Market Approval (PMA):

PAGE 1 PAGE 2

May 1998

Approval Letter from the FDA to Nevyases dated 05/14/98 Re: Contrast Sensitivity & Increased 'Subjects':

PAGE 1 PAGE 2 PAGE 3

July 1998

"Conditional" Approval Letter from the FDA to Nevyases:

PAGE 1 PAGE 2 PAGE 3

September 1998

Approval Letter from the FDA to Nevyases:

PAGE 1 PAGE 2

December 1998

Approval Letter from the FDA to Nevyases:

PAGE 1 PAGE 2

January 1999

Deviations of Nevyas Eye Associates, As Stated In Letter from the FDA dated 01/07/99:

PAGE 1 PAGE 2 PAGE 3

Approval Letter from the FDA to Nevyases dated 01/20/99:

PAGE 1 PAGE 2

November 1999

Request Letter from the FDA to Nevyases:

PAGE 1 PAGE 2

January 2001

Letter from the FDA to Nevyases Re: Non-Response To Request:

PAGE 1 PAGE 2

April 2001

Request Letter from the FDA to Nevyases:

PAGE 1 PAGE 2 PAGE 3

July 2001

Disapproval Letter from the FDA to Nevyases:

PAGE 1 PAGE 2 PAGE 3 PAGE 4 PAGE 5 PAGE 6 PAGE 7 PAGE 8

August 2001

Supplement Disapproval Letter from the FDA to Nevyases

PAGE 1 PAGE 2 PAGE 3

February 2002

Nevyases Deviations and discrepancies continue almost 5 years into their study - Letter from the FDA to Nevyases

PAGE 1 PAGE 2 PAGE 3 PAGE 4

April 2002

IDE Deficiencies Request Letter from the FDA to Nevyases

PAGE 1 PAGE 2 PAGE 3
 
Nevyas Investigational Laser PDF Print E-mail

The following documents were submitted to the FDA from 1997 through 2001 regarding the "Nevyas Investigational (Black Box) Laser"

The laser was built by Ed Sullivan who, according to the excerpt below, was already under scrutiny by the FDA.

"Ed Sullivan, doing business as ExSull, Drexel Hill, Pa, has been put on notice by the FDA that the agency regards him &quot;clearly as a manufacturer with multiple manufacturing sites&quot; subject to FDA rules and regulations and, if he makes another one of these excimer lasers &quot;which are unapproved devices,&quot; he will be in violation of the federal Food, Drug and Cosmetics Act and subject to legal penalties, according to top-ranking FDA officials within the national Division of Enforcement." [as written in The Journal of Refractive Surgery - Volume 11 (5) * September/October 1995 * News and can be found at the url address:

http://www.slackinc.com/eye/jrs/vol115/news1.htm">http://www.slackinc.com/eye/jrs/vol115/news1.htm

Click PAGE # to open page in new window

NOTES: Page numbers with an "l" designate the page as landscape. All BLUE font on this page designate links. Some PDF documents may require a decrease in magnification for better clarity.

PDF Documents (for high speed or download)

To view ALL DOCUMENTS listed below in one PDF (two parts), click HERE.

1997 Reports

PAGE 1 - Prohibition of promotion and other practices. - 21 CFR. § 812.7

PAGE 2 - Protocol NEV-97-001: Myopia with or without astigmatism - Study Procedures.

PAGE 3 - Protocol NEV-97-001: Inclusion/Exclusion Criteria.

PAGE 4 - IDE Supplement - Question/Response.

PAGE 5 - Protocol NEV-97-001: Ethical and regulatory considerations.

PAGE 6 - Protocol NEV-97-001: Complications, Adverse Events, & Serious/Unanticipated Adverse Device Effects.

PAGE 7 - Protocol NEV-97-001: Inclusion/Exclusion Criteria Revision.

PAGE 8 - Protocol NEV-97-001: Screening for Refractive Surgery Eligibility.

PAGE 9 -  PAGE 10 - Protocol NEV-97-001: Clinical Study Data Submitted to FDA.

1998 Reports

PAGE 1 - PAGE 2 - PAGE 3 - PAGE 4 PAGE 5 - PAGE 6 - PAGE 7 - PAGE 8 - PAGE 9 - PAGE 10 - PAGE 11 - FULL - Protocol NEV-97-001: Study IDE Supplement Annual Report

PAGE 1 - PAGE 2 - PAGE 3 - FULL - Protocol NEV-97-001: Study IDE Annual Report Supplement

PAGE 1 - PAGE 2 - PAGE 3 - FULL - Protocol NEV-97-001: Study Changes, Progress towards PMA Approval, Safety & Efficacy for Study Eyes (Notice the 100% for cumulative UCVA of 20/40 or better, the 0 counts for the BSCVA worse than 20/40 or better, or for the BSCVA worse than 20/25, 6 months after my surgery).

1999 Reports

PAGE 1 - PAGE 1 - FULL - The FDA states "We continue to be concerned that your ablation is likely to have multifocal properties, which means that some light will be out of focus even at tine best focal plane".

PAGE 1 - PAGE 2 - PAGE 1 - FULL - Safety & Efficacy for Study Eyes, Page 1 (Notice the 100% for cumulative UCVA of 20/40 or better, the 0 counts for the BSCVA worse than 20/40 or better, or for the BSCVA worse than 20/25, 1 1/2 years after my surgery). The charts on pages 2 and 3 also do not show adverse events or complications.

2001 Reports

PAGE 1 - PAGE 2 - FULL - Protocol Deviations & Summary of Complications and Adverse Events.

PAGE 1 - PAGE 2 - PAGE 3 - FULL - Nevyas Investigational Study charts submitted to the FDA.

PAGE 1 - The FDA states "There was no documentation to show that the CI notified the IRB about all amendments, changes or significant deviations to the protocol [per IRB requirements] prior to implementation" "The firm is not complying with the Investigator Agreement which was signed and dated by the Clinical Investigator at the beginning of the Clinical Study"; and "There was a lapse of IRB approval for the protocol: NEV-97-001 from 8/3/2000 until 8/29/2000 according to IRB, lapse notices and the IRB annual reapproval letter".

 
Nevyases Promotion of an Investigational Device PDF Print E-mail

Nevyas' Promotion of An Investigational Device

Guidelines, regulations, and laws were in effect prior to the Nevyas' investigational study.

Click PAGE # to open page in new window

NOTES: Page numbers with an "l" designate the page as landscape. All BLUE font on this page designate links.

From the Federal Trade Commission:

PAGE1 - PAGE2 - FULL - The FTC enforces the Federal Trade Commission Act (FTC Act), which among other things prohibits deceptive or unfair practices in or affecting commerce. 15 U.S.C. §§ 45, 52-57. An advertisement is deceptive under Section 5 of the FTC Act, and therefore unlawful, if it contains a representation or omission of fact that is likely to mislead consumers acting reasonably under the circumstances, and that representation or omission is material, that is, likely to affect a consumer's choice or use of a product or service. It is important to note that advertisers are responsible for claims that are reasonably implied from their advertisements, as well as claims that are expressly stated.

In addition, under the FTC Act, advertisers must have substantiation for all objective claims about a product or service before the claims are disseminated In the context of claims about the safety, efficacy, success or other benefits of RK or PRK, substantiation will usually require competent and reliable scientific evidence' sufficient to support the claim that is made.

From the Food and Drug Administration (FDA):

PAGE1 - PAGE2 - FULL - As you know, the FDA approved applications for premarket approval (PMAs) from Summit Technology, Inc. and from VISX Inc_ for their excimer lasers for the correction of mild to moderate myopia in patients with minimal astigmatism Based on the submitted data, these models were approved for refractive correction only by photorefractive keratectomy (PRK) of the corneal surface. Data were not submitted to support the use of these lasers for laser assisted in-situ keratomileusis (LASIK), laser scrape, astigmatism, hyperopia, or multipass or multizone software algorithms. Currently, these are the only lasers approved by FDA for refractive correction and the only refractive indications for which they are approved. The dioptric ranges indicated in the PMA are based on data submitted by these companies in their applications. Data on higher myopia and astigmatism were not submitted, and therefore the approvals did not provide for their treatment. All other lasers being used for refractive surgery, however manufactured or obtained, should be regarded as investigational devices and patients should have the usual human subject protection of institutional review board (IRB) protection, informed consent and an IDE approval by FDA.

21 C.F.R. 夤 812.7 Prohibits promotion of an investigational device!

21 C.F.R. 夤 812.7

CODE OF FEDERAL REGULATIONS

TITLE 21--FOOD AND DRUGS

CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN

SERVICES

SUBCHAPTER H--MEDICAL DEVICES

PART 812--INVESTIGATIONAL DEVICE EXEMPTIONS

SUBPART A--GENERAL PROVISIONS

§§ 812.7 Prohibition of promotion and other practices. A sponsor, investigator, or any person acting for or on behalf of a sponsor or investigator shall not:

(a) Promote or test market an investigational device, until after FDA has approved the device for commercial distribution.

(b) Commercialize an investigational device by charging the subjects or investigators for a device a price larger than that necessary to recover costs of manufacture, research, development, and handling.

(c) Unduly prolong an investigation. If data developed by the investigation indicate in the case of a class III device that premarket approval cannot be justified or in the case of a class II device that it will not comply with an applicable performance standard or an amendment to that standard, the sponsor shall promptly terminate the investigation.

(d) Represent that an investigational device is safe or effective for the purposes for which it is being investigated.

However, the Nevyas' DID promote:

On radio:

PAGE 1 - PAGE 2 - PAGE 3 - PAGE 4 - FULL - Nowhere did the Nevyases state that they were part of an investigational study or that their laser was also an investigational device.

And in an infomercial on MDTV:

PAGE 1 - PAGE 2 - PAGE 3 - FULL - The same applied to their infomercial.

 
FDA Inspection Reports of the Nevyas' Facility PDF Print E-mail

Click PAGE # to open page in new window

NOTES: Page numbers with an "l" designate the page as landscape. All BLUE font on this page designate links.

FDA Issued Inspection Report of Nevyas Eye Associates facility dated 11/02/1998:

PAGE 1PAGE 2PAGE 3PAGE 4PAGE 5
PAGE 6PAGE 7PAGE 8PAGE 9PAGE 10
PAGE 11PAGE 12PAGE 13PAGE 14PAGE 15
PAGE 16PAGE 17PAGE 18PAGE 19

FDA Issued Inspection Report of the Nevyas' facility dated 05/10/2001:

PAGE 1PAGE 2PAGE 3PAGE 4PAGE 5
PAGE 6PAGE 7PAGE 8PAGE 9PAGE 10
PAGE 11PAGE 12PAGE13PAGE 14PAGE 15
PAGE 16PAGE 17

The 2nd inspection resulted in an FDA483 issued by the FDA.

Read more...
 
Nevyas' Deviation From Standard of Care PDF Print E-mail

Affidavit Of Dr. Stephen Orlin

This affidavit is from Dr. Stephen Orlin, an expert witness of the Nevyases in several lawsuits. He clearly states "Retinopathy of Prematurity, in and of itself, is not a contraindication to LASIK surgery". It also states as an expert of the Nevyases, that my retinas were "healthy" for practical purposes of LASIK.

AFFIDAVIT IN RICH TEXT

AFFIDAVIT

I, Stephen Orlin, M.D., do affirm the following:

1. I have been made aware of the statements made by plaintiff's counsel that the brochures that I give to patients state that they must have healthy retinas free from disease in order to have LASIK. (See Plaintiff's Reply to Motion in Limine to Preclude Testimony of Plaintiff's Experts (Frye) of Dr. Anita Nevyas-Wallace.)

2. The statement made in that brochure is being taken out of context by plaintiff's counsel.

3. The statement made in that brochure does not apply to stable retinas, such as the retinas of the plaintiff at the time that he underwent LASIK surgery by Dr. Anita Nevyas-Wallace.

4. Mr. Morgan's retinas were "healthy" for the purposes described in the brochure.

5. Retinopathy of prematurity, in and of itself, is not a contraindication to LASIK surgery.

6. There is and was absolutely no literature, either in 1998 up and through to the present, stating that retinopathy of prematurity, in and of itself, is a contraindication to LASIK surgery. Moreover, there have not been any animal studies performed to indicate that retinopathy of prematurity, in and of itself, is a contraindication to LASIK surgery, and no indication in this case that Anita Nevyas-Wallace, M.D. was using the plaintiff as a "guinea pig" as asserted by plaintiff's counsel.

7. I stand by my previously expressed opinions as set forth in my previous reports in this case.

Stephen Orlin, M.D.

DR. ORLIN TESTIFIES ON BEHALF OF NEVYAS


As Noted by Drs. James Salz, Terrence O'Brien, & Kenneth Kenyon regarding myself and two other LASIK casualties.

All links will open PDF documents in a new window.

DR. SALZ' REPORTS

The following reports were after seeing Dr James Salz, who afterwards became an expert in my medical malpractice lawsuit against my LASIK doctors. These are his reports, and are filed with the Philadelphia courts:

This was what was determined after waiting for all of the medical reports to come together, as was reported from my attorney to the arbitrator:

1. After LASIK, Mr. Morgan saw Nevyas-Wallace's group for almost 2 years, as well as several other ophthalmologists, seeking to correct his worsened vision. The records confirm that Dominic told Nevyas-Wallace and the other ophthalmologists what each told him, that Dominic obtained some copies of records to take from one to the other, and that sometimes the ophthalmologists wrote or telephoned each other, but no ophthalmologist had copies of all the medical records from all the other ophthalmologists.

2. The only persons to review copies of the entire medical records appear to be Dr. O'Brien (after he became an expert) and Dr. Salz. One cannot be certain what Dr. Orlin and Dr. Willis reviewed.

The early post-LASIK period:

3. Nevyas-Wallace initially told Dominic that all his problems were temporary and would pass with time, first 3 to 6 months, then 6 to 12 months. Meanwhile, Nevyas-Wallace wrote in the records that there were problems in centering the laser ablation during the left eye LASIK procedure (operative note 4/23/98), with resultant temporal decentration in the left eye (medical records 4/27/98, 5/4/98), and nasal decentration in the right eye (medical record 7/6/98).

4. Three other ophthalmologists seeing Dominic Karen Fung, M.D. (medical record 8/3/98), John Dugan, M.D. (medical record 8/25/98), and Michael Belin, M.D. (medical record 1/25/99) told Dominic and wrote that they were concerned with LASIK causing decentration problems. Dr. Dugan sent Dominic to Dr. Laibson. [see telephone call note to Laibson's partner Dr. Rapuano in Laibson records] Dr. Dugan also sent Dominic to Johns Hopkins, [deposition Dugan p. 73] and after Dr. Dugan talked with Dr. Guyton (see below, on 6/19/00) he wrote both that he was uncertain, as well as writing about decentration.

The later post-LASIK period:

5. Peter Laibson, M.D. wrote (letter 2/23/99): "I think it is either a retinal problem (you are familiar with his past history of regressed retinopathy of prematurity with peripheral lattice degeneration) or possibly other factors, which are not obvious on the objective examination."

When deposed, Dr. Laibson would not answer all pertinent questions. Asked by defendants if LASIK was responsible for Dominic's loss of visual acuity, Dr. Laibson said that Dominic*s problems were more than the LASIK flaps [deposition Laibson p. 20-21] and "I can say that the LASIK surgery looked like it was done appropriately; and that as far as visual loss is concerned, I don't know how to answer that question." [deposition Laibson p.24, 25] When asked again by defendants if LASIK was responsible for Dominic's loss of visual acuity, he said, "I don't know."[deposition Laibson p.26] When further pressed by defendants, he rephrased the question to avoid answering what was asked: "I felt it was not likely that if he really did have 20/40 that the LASIK was responsible for the reduction in vision to 20/70." [deposition Laibson p.27, emphasis added] When plaintiff's attorney asked, "Doctor, would you consider the use of the suction cup and the increased intraocular pressure as one of the other factors that you're referring to?" he answered, "I have no comment on that" [deposition Laibson p.38] and later, "I'm not an expert."[deposition Laibson p 43] He explained that the cornea alone could not explain Dominic's problem, so there had to be another problem. [deposition Laibson p 55-56]

6. Nevyas-Wallace wrote (medical record 3/8/99): "Phone call from patient...He says Dr. Michael Belin and Dr. Peter Laibson each said the cornea looks fine and that the problem must be retinal." Thereafter Nevyas-Wallace continued to assure Dominic that his problems would clear up with time, but what was written in Nevyas-Wallace's medical records changed.

7. Sheldon Morris, M.D. when asked specifically if cataracts were present, wrote there were no significant cataracts and Low VA [visual acuity] related to retinal problems."[medical record 4/17/00] At deposition Dr. Morris said he did not know if the retinal problems were worsened by the LASIK procedure or independent of LASIK. [deposition Morris p. 22]

8. Nevyas-Wallace wrote (medical record 4/26/99): "Impression: Retinal problem. Rule out hysteria."

9. Paul Beer, M.D. wrote (letter 7/21/99): "The explanation that was raised by one of the previous consultants, that his refractive surgery is not aligned with the physical location of his macula, may be very reasonable."

10(A). Nevyas-Wallace wrote (medical record 7/26/99): "Impression: Topography shows central ablation, and no increase (in vision) with contact lens. Therefore, problem is retinal."

10(B). Nevyas-Wallace wrote (medical record 10/11/99): "Impression: Discussed in detail - that as per Drs. Laibson, O'Brien, and Belin, the cornea and topography are excellent and that slight drop in visual acuity is symptomatic with marginal acuity at the onset. Also that retinal factors including retinopathy of prematurity likely to be responsible." This implied that retinal factor other than retinopathy of prematurity were present, and Nevyas-Wallace repeated her implication [deposition Nevyas-Wallace p. 212]: "I discussed matters in detail and I explained to him that I agreed with Dr. Laibson and Dr. O'Brien and Dr. Belin in their assertions that both the appearance of the cornea and the corneal topography are excellent and that slight drop in visual acuity is symptomatic and that retinal factors, including his retinopathy of prematurity, are likely to be responsible."

11. Eugene DeJuan, M.D. wrote for diagnoses: "Question of optical phenomena and retinal degeneration or ischemia secondary to vacuum [cup for LASIK]." (Johns Hopkins medical record 11/29/99)

12. David Fischer, M.D. wrote (letter 3/3/00): "The more insidious causes of diminished vision concern the retina which your LASIK surgeons felt were the culprit. Your fluorescein angiogram was felt to be normal as were your visual fields. The ERG showed mild retinal dysfunction, cause to be determined. During LASIK procedures a suction cup is placed on the eye causing increased intraocular pressures. Could this be a factor as a long-term optic neuropathy which may also be related to your retinopathy of prematurity? I'm afraid these are questions that I cannot answer and I'm hopeful that the doctors at Johns Hopkins can elicit these answers for you."

13. David Guyton, M.D. saw Dominic at Johns Hopkins in June 2000. Dr. Guyton stated, "I could say from that that the refractive surgery wasn't the only thing which was decreasing his vision." [Guyton deposition p. 19] When Dr. Guyton was asked by defendant, "What amount is it would not be related to Lasik then, over from where to where?" he explained that LASIK was responsible for the decrease to 20/70 and postulated cataracts (unrelated to LASIK) for 20/70 to 20/125. [Guyton deposition p. 20-21] Dr. Guyton stated that he deduced cataracts by a process of elimination [Guyton deposition p. 45] since they were barely visible, and suggested waiting [two years] to see if there would be any progression. Absent progression he felt cataracts could not be part of Dominic's visual problem. (letter 6/19/00 and deposition pp. 22, 23, 38, 39).

14. The other two Johns Hopkins doctors, Eugene DeJuan, M.D. (with his fellow, Joseph Harlan, M.D.) and Terrence O'Brien, M.D., did not believe the barely visible cataracts were significant, but did not regard waiting as unreasonable.

15. Defense expert Dr. Orlin examined Dominic 1/30/02 and stated, "over the past two years, these [cataracts] have remained minimal and non-progressive," [Orlin report 6/12/02, p. 2] and neither he nor defense expert Dr. Willis suggested any significant visual loss from cataracts.

16. When plaintiff's expert Dr. Salz examined Dominic 4/27/02, almost 2 years after Dr. Guyton, there still was no cataract progression. Dr. Salz reported no cataract problems, and was then able to conclude with medical certainty that Dominic's problems were causally related to decentered laser ablation, and retinal and optic nerve damage.

17. Terrence O'Brien, M.D., having waited 2 years after Dr. Guyton, agreed with Dr. Salz and became a plaintiff expert. All experts' reports were "set aside" in determining outcome of arbitration.


DR. SALZ' REPORTS - RICH TEXT

--------------------------------------------------------------------------------

Beverly Hills Eye Medical Group, Inc.12561 Promontory RoadLos Angeles, Ca. 90049Phone 323 653-3800 Fax 310 472-4244April 27,2002

Steven A. Friedman, M. D. Physician and Attorney at Law 850 West Chester Pike, 1st Floor Havertown, PA 19083

RE: Dominic Morgan's examination on 4/27/02

Dear Dr. Friedman:

As you requested, I have examined your client and this report will summarize my findings.

History Mr. Morgan stated that his best-corrected visual acuity was never better than 20/50 on numerous previous examinations secondary to his retinopathy of prematurity. The 20/50 visual acuity was confirmed on his driver test examination. He also stated that he went to the Nevyas Eye Center because he heard a radio commercial on KYW. He was told he was a " good candidate" for LASIK despite his ROP. After surgery on his left eye he complained about the quality of his vision and problems with his night vision and was told that it was normal at that stage and would improve with time. These assurances were the reason he consented to surgery on his right eye.

His current complaints include the following: vision fluctuates a great deal, some days worse than others and changes during the same day depending on lighting conditions; cannot see to drive at night; he still has a driver's license but has essentially given up driving; at dusk, everything becomes even more blurry and he sees starbursts around lights; during the day he gets by OK, cannot read road signs but he feels he could drive in familiar areas; all these symptoms are worse in his right eye, especially at night.

Examination:

Uncorrected visual acuity OD 20/100 +2, OS 20/100 -

VA with present glasses OD -1.00 -0.50 x 11 = 20/100, OS -0.75 -0.25 x 26 = 20/80 -1

Refraction OD -0.50 -0.50 x 90 = 20/80 +, OS -1.50 = 20/80 +

Cycloplegic refraction OD -0.50 -0.50 x 90 = 20/100 with triple images of chart letters

OS - 1.25 = 20/100 with triple images of chart letters

1

--------------------------------------------------------------------------------

Keratometry OD 41.50/41.75 x 107 clear mires, OS 42.25/42.62 x 90 clear mires Pupil diameter in dark room with pupilscan OD 6.4mm OS 6.5 mm Pachymetry OD .46 mm OS .48 mm

Slit lamp examination—clear corneas with well-healed LASIK flaps OU, normal pupils, no afferent pupil defect, lens shows faint trace nuclear sclerosis in the posterior half of the lens nucleus while the anterior half is clear.

Fundus examination with pupils dilated, both direct and indirect reveals hypoplastic optic nerves with essentially no cup and no obvious pallor OU, prominent temporal peri-papillary atrophy and temporal displacement of macula OU

Humphrey Topography shows relatively small but well centered ablations in both eyes with the lower end of the ablation at the edge of the photopic pupil of about 3 mm. The corneal irregularity measurements are increased to 2.63 OD and 2.49 OS (normal up to 1.5) copy enclosed

Wavescan readings with the Alcon Humphrey System are included. These were performed with normal lighting with pupils of 4.59 mmOD and 4.23mm OS and again with pupils dilated to more closely simulate night conditions when the pupils were 7.6mm OD and 7.4mm OS. The defocus and astigmatism readings with the smaller pupil are quite normal and agree with the minor residual refractive error in both eyes. Both of these values increase with larger pupils because the unablated area of the cornea is measured and this simply reflects the relatively small ablation diameters. The most common aberrations following LASIK are Coma and Spherical Aberration and these values are acceptably low with pupils of about 4.5 mm. For example the spherical aberration for OD is 0.38 OD and 0.16 OS. When the pupils are dilated simulating night conditions, spherical aberration increases to 2.33 OD and 1.72 OS. This represents almost a six-fold increase for OD and a tenfold increase for OS.

Comment: Mr. Morgan has been examined by several highly qualified experts since his LASIK surgery in an attempt to explain the decrease in his best-corrected visual acuity. The possible mechanisms include retinal damage, optic nerve damage, a combination of both; optical problems related to positive angle kappa and an ablation centered over the pupil, and early cataract changes. Based on my examination, I attribute his loss of vision to a combination of all except the cataract. I do not feel the minimal lens opacity is sufficient to explain his loss of vision. This would not explain why his vision became worse immediately after the surgery in both eyes. Dr. Guyton suggested the minimal cataracts as a possible explanation in June of 2000 and suggested that if the cataracts were at fault we would expect to see progression in the lens changes and further decrease in his visual acuity. It is almost 2 years since that exam and today, his visual acuity was better than the 20/125 recorded by Dr. Guyton and the lens changes are still minimal so this goes against the thought that the cataracts are at fault.

2

--------------------------------------------------------------------------------

Mr. Morgan's increased night symptoms are readily explained by the small ablation diameters evident on his topography combined with the fact that his scotopic pupils are about 6.5 mm. The dramatic increase in his spherical aberration in both eyes when his pupils are dilated correlates well with his subjective complaints. The spherical aberration is also higher in the right eye and he has more complaints about his night vision in that eye.

Sincerely,

signature on original scanned document Nevyas v. Morgan

3

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Beverly Hills Eye Medical Group, Inc.12561 Promontory RoadLos Angeles, Ca. 90049Phone 323 653-3800 Fax 310 472-4244

April 27, 2002

Steven A. Friedman, M. D. Physician and Attorney at Law 850 West Chester Pike, 1st Floor Havertown, PA 19083

RE: Dominic Morgan v Nevyas Eye Associates-report on standard of care deviations

Dear Dr. Friedman:

As you requested, I have examined your client and reviewed the records you have forwarded to me over the last 3 months. This report will summarize what I believe to be deviations from the standard of care by Nevyas Eye Associates in the treatment of your client, Dominic Morgan. His examination will be summarized in a separate report.

1. Mr. Morgan was not an appropriate candidate for an FDA study where the protocol lists under B, 6 "best corrected visual acuity of 20/40 or better in both eyes". Even without the FDA study criteria, he would not be considered a "good candidate for LASIK". Mr. Morgan stated very clearly in his record and maintains by history that his best-corrected spectacle visual acuity was never better than 20/50. He did have a refraction on March 10, 1998, which showed a best corrected visual acuity of 20/40-2 in each eye. While this is close to 20/40 it is not 20/40. A letter from Dr. Anita Nevyas to Dr. Bellin on 12-18-98 reported his preoperative vision as 20/40-2 to 20/50 and a letter to Dr. DeJuan on March 27, 2000 reports his best-corrected visual acuity as 20/50. A letter from Dr. Herbert Nevyas to Dr. Grace Tammera on 8/20/98 reported that he had 20/50 vision in each eye with full correction before his surgery. This fact combined with his history clearly noted in the record should have disqualified him from an FDA study requiring best corrected visual acuity of 20/40 or better. Rather than emphasizing the likely increased risks of performing LASIK in a patient with already compromised vision secondary to retinopathy of prematurity (ROP), the notes at the Nevyas Eye Center state that he is a "good candidate for LASIK". Exclusion criteria C, 5 of the protocol lists the "Presence of any clinically significant abnormality on physical or ophthalmic examination that would contraindicate outpatient refractive surgery." ROP would be a clinically significant abnormality. I do not know of any surgeon who has performed LASIK on a patient with Mr. Morgan's degree of ROP. He was simply not an appropriate candidate.

1

--------------------------------------------------------------------------------

There are 3 problems with performing LASIK on eyes with ROP. The first is that the retina is already compromised by the primary disease and the increased pressure in the eye (often 3 to 5 times normal) can by itself damage a normal retina and this risk would be increased in an already compromised retina where the macula has been stretched or dragged temporally. Although exams by retinal specialists has failed to document obvious retinal damage, one cannot rale out hypoxic or pressure induced damage to the macular area during the cutting of the flap which would account for his decreased vision.

He does now have abnormal electroretinograms as documented on April 8, 2002 and February 20, 2000, which indicate abnormal rod and cone function. This is not surprising in a patient with ROP but of course we do not have pre LASIK studies to determine if these abnormalities were increased after his LASIK. If a preoperative ERG was in fact abnormal, that would be an additional reason combined with the clinical appearance and best-corrected vision of 20/50 to exclude him from the study. If a preoperative ERG was normal, we would then have objective evidence that the LASIK surgery caused it to become abnormal.

The second problem with a patient with ROP is that optic nerve and the nerve fiber layer of the retina are more susceptible to damage from the increased intraocular pressure from the application of the suction ring. • Dominic does have abnormal optic nerves, which appear to by hypoplastic in the photos from 4/6/98 at the Nevyas Eye Center and by my exam. The report by Dr. DeJuan at Hopkins also describes "anomalous" optic discs. These small hypoplastic optic nerves are more prone to damage during LASIK. Cases of optic nerve damage have been reported following LASIK have been reported even in normal eyes. The LASIK procedure can cause subclinical ischemic damage to the optic nerve or nerve fiber layer of the retina but not enough to result in obvious optic nerve atrophy or pupil defects. The visual field testing (Goldman) performed at Wilmer shows paracentral scotomas in both eyes and the interpretation by Dr. Zack on 12/6/99 describes, "specific loss including a number of common disorders, most commonly glaucoma." Clearly Dominic does not have glaucoma so these field defects point to damage from the increased intraocular pressure during LASIK in an abnormal optic nerve. The GDX study from March 27, 2000 also shows abnormal nerve fiber layers in both eyes which would usually indicate glaucoma but here is simply an indication of his ROP. If feasible I recommend Patterned Visual Evoked Potential testing to evaluate his optic nerve function. The third problem with an ROP patient involves the controversy of whether to center the excimer ablation over the pupil, as recommended by Guyton Ellis and Hunter, or over the visual axis, as suggested by Wachler and Buzzard. Although this argument is often moot in most normal eyes, the dragged macula in ROP and the significant positive angle Kappa make this a more significant decision in an

2

--------------------------------------------------------------------------------

ROP patient. Indeed, the inability of Nevyas to be certain where to properly center the excimer ablation in an ROP patient is another reason why LASIK was inappropriate. The topography following the LASIK appears to be well centered over the pupil. Because Mr. Morgan visual axis or "line of sight" is not looking through the center of the pupil, this may be partially responsible for his visual aberrations and decreased vision. It does not appear that this issue was ever discussed with Mr. Morgan as a potential problem with doing surgery on him as opposed to a truly "good candidate. The Nevyas note of 4/27/98 mentions the "patient was looking nasal to fixation target intraop" and that there was "temp decentration OS." It is possible that Mr. Morgan's line of sight to his temporally pulled macula passes through a peripheral portion of his ablation rather than the central portion and that may explain some of his decreased vision and night symptoms of glare and ghost images. Under these circumstances it may have been more appropriate to center his ablation over the line of sight rather than the pupillary center. This mismatch between the center of the ablation and the temporally displaced macula as a possible explanation for Mr. Morgan's difficulties is also mentioned in the letter from Dr. DeJuan and the letter from Dr. Paul Maurius Bear dated 7/21/99. 2. Violation of FDA and Code of Federal Regulations on promotion and other practices. These regulations state that the investigator shall not: "(a) Promote or test market an investigational device until the FDA has approved the device for commercial distribution and (d) Represent that an investigational device is safe or effective for the purposes for which it is being investigated." Mr. Morgan states and it is confirmed on his patient history dated 3/10/98 that he came to the Nevyas Eye Associates because he heard a radio commercial on station KYW. I have reviewed the script of radio advertisements, the Nevyas web pages, and a promotional Videotape of a program that was shown on cable television and may have been distributed to patients. I have been told that all of these materials were used during the FDA investigation of the Nevyas Laser. None of these materials included the FDA required warning that the device is limited to investigational use only. The ads also represent that the procedure is safe, and in fact the TV ad shows a simulated blurred 20/200 vision quickly dissolving into a sharp 20/20 vision. There are numerous other representations that the procedure is safe and effective. If patients were responding to these advertisements and then were entered into the FDA study, that would represent a serious deviation from the standard of care and one that I am sure the FDA would be interested in these practices. It would also appear that the poor results obtained by Mr. Morgan with the significant decrease in his best corrected spectacle visual acuity of more than 10

3

--------------------------------------------------------------------------------

letters were not properly reported to the FDA and that more patients were recruited for the study than were authorized by the FDA. 3. Performing surgery on the right eye when the left eye sustained a loss of best-corrected visual acuity from 20/40 -2 to 20/70. On 4/27/02 the clinical notes state that the patient "feels vision is weaker since Fri. and night time is a problem." The refraction was -0.25 -0.75 x 80 = 20/70 (the target for this eye was mono vision for the left eye of about -2). Thus the patient had a significant over response to the laser, had complaints about the quality of his vision and his night vision, and had lost at least 2 lines of best-corrected visual acuity. Despite these problems, Dr. Nevyas impression was that he was "doing well" and recommended and performed LASIK surgery on the dominant right eye on 4/30/98. The imbalance between the two eyes that the patient experienced should have been corrected with a contact lens or glasses in the right eye while the situation in the left eye was evaluated. The left eye eventually regressed to about -1.25 so it may actually have been possible for him to continue simply wearing glasses and a contact lens may not have been necessary. This is especially true since the patient had a previous history of strabismus surgery and he may not have had true stereopsis so the anisometropia may have been easily tolerated and surgery on the right eye could have been deferred indefinitely. 4. Comment: Mr. Morgan has been examined by several highly qualified experts since his LASIK surgery in an attempt to explain the decrease in his best-corrected visual acuity. The possible mechanisms include retinal damage, optic nerve damage, a combination of both; optical problems related to positive angle kappa and an ablation centered over the pupil, and early cataract changes. Based on my examination and records review, I attribute his loss of vision and visual complaints to a combination of all except the cataract. I do not feel the minimal lens opacity is sufficient to explain his loss of vision. This would not explain why his vision became worse immediately after the surgery in both eyes. Dr. Guyton suggested the minimal cataracts as a possible explanation in June of 2000 and suggested that if the cataracts were at fault we would expect to see progression in the lens changes and further decrease in his visual acuity. It is almost 2 years since that exam and today, his visual acuity was better than the 20/125 recorded by Dr. Guyton and the lens changes are still minimal so this goes against the thought that the cataracts are at fault. Within a reasonable degree of medical certainty, it is my opinion that LASIK caused all the problems discussed above and in my report to occur. LASIK surgery usually does not provide a patient with vision better than his or her best corrected vision with spectacles or contact lenses. Although common, this surgery is not without risk, and the practice is not to perform surgery on patients who already have compromised vision secondary to severe eye conditions. By avoiding patients whose vision is already compromised to this degree we leave the patient a "safety net" in case the procedure leaves them with less than

4

--------------------------------------------------------------------------------

desirable results. Certainly Mr. Morgan's ROP places him within a category of patients who needed that net, and Dr. Nevyas-Wallace took that net away. Yours truly, James J. Salz, M. D. signature on original scanned document Nevyas v. Morgan

5

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Beverly Hills Eye Medical Group, Inc.12561 Promontory RoadLos Angeles, Ca. 90049Phone 323 653-3800 Fax 310 472-4244

September 16, 2002

Steven A. Friedman, M. D. Physician and Attorney at Law

850 West Chester Pike, 1st Floor Havertown, PA 19083

RE: Reply to defense expert reports

Dear Dr. Friedman:

I have reviewed the additional documents you forwarded to me. These documents include: deposition testimony of Drs. Herbert Nevyas, Anita Nevyas, Joan Nevyas, John Dugan, Sheldon Morris, Ira Wallace, Edward Deglin, Richard Sterling, MRI reports, IME report of Dr. Stephen Orlin, his patient information guide, web page document as well as some FDA documents and appointment documents for Herbert and Anita Nevyas to the Pennsylvania Eye Surgery Institute. The review of these additional records does not change any of the opinions previously expressed in my original report. I have also reviewed the expert report of Dr. Stephen Orlin and Dr. Amos Willis about your client Dominic Morgan. Dr. Orlin focused on 4 aspects of Mr. Morgan's condition.

1. Progressive cataract formation. I agree with Dr. Orlin that Mr. Morgan's "nuclear sclerotic" cataracts are minimal, not responsible for his visual loss, non- progressive, and not related to his Lasik surgery.

2. Retinal damage. I agree with Dr. Orlin that Mr. Morgan's past ophthalmic history was complicated and significant for Retinopathy of Prematurity (ROP). I would agree that there was no medical reason to evaluate his retina for his retinopathy of pre-maturity (ROP) if surgery was not being contemplated. The term retinopathy in his diagnosis of ROP means the retina is abnormal. Lasik is customarily performed on patients with normal retinas and so there would be no deviation of the standard of care to not perform visual field testing and ERG's on patients with normal retinas undergoing Lasik. This was not the case with Mr. Morgan, however. Since his retina was abnormal, with a pulled macula and decrease in his best corrected visual acuity non invasive testing like visual fields and ERG would have been a valuable way to assess the extent of his damage. Dr. Orlin's patient information guide about laser vision correction states in response to the question How do I know if I am a good candidate for laser vision correction? "Patients who are 21 years of age or older, and have healthy eyes which are free of retinal problems, corneal scars, and any eye disease are suitable."

1

--------------------------------------------------------------------------------

It is simply not within the standard of care to perform LASIK on patients' with ROP like Dominic. Nevyas's own protocol and criteria are written evidence confirming this standard of care. During the LASIK procedure the intraocular pressure is raised 3 to 4 times the normal value. Optic nerve damage and retinal damage have rarely been described as a complication of LASIK in normal eyes. Since there is no other explanation for his decreased vision, it has to be concluded that the procedure damaged his already abnormal retinas and optic nerves. Mr. Morgan could not give informed consent since his ROP should have excluded him from surgery and he was not given that information. It is clear that Dominic would not have been harmed had he not undergone the LASIK surgery. The fact that Dominic can read 20/40 on a near vision test certainly does not mean he has 20/40 distance vision as Mr. Morgan has residual myopia and is thus receiving a magnified near image. The fact that he voluntarily read 20/40 at near gives evidence that he is giving us an honest examination and is not trying to make his condition appear to be worse than it is. It is not uncommon for nearsighted patients to have better uncorrected near vision than their best corrected distance vision.

3. Ablation centration. Mr. Morgan's postoperative topography merely shows that his ablations are centered over his pupils, not necessarily over his line of sight. . In most patients, the difference between centration over the pupils vs. the line of sight is minimal but in Dominic it was significant because of his ROP and markedly abnormal positive angle kappa. I would agree that the lack of improvement in his vision with a hard contact lens rules out significant irregular astigmatism as a cause. It does not preclude loss of vision caused by the fact that he is not looking through the optical centers of his ablations, which are centered over his pupils. He is looking through a peripheral area of the ablation, rather than the center of the ablation. The lack of improvement with a hard lens does point to damage to the retina, nerve, or both as the primary cause for most of his impairment.

4. Aberrations. I would agree that the higher order aberrations are not responsible for Mr. Morgan's daytime vision but they do provide objective evidence of his night vision complaints. He most likely would have had the same increase in night aberrations whether or not he had ROP. He was at increased risk of these aberrations because of his large scotopic pupils (6.5mm). In his report dated May 29th, 2002 Dr. Willis states that 20/40 -2 would be considered by most physicians to represent 20/40 visual acuity. Most physicians have not conducted and are not familiar with PDA studies. Mr. Morgan was being enrolled in an PDA study, which specified a minimum requirement of best-corrected vision of 20/40. It did not specify vision of approximately 20/40, around 20/40 or 20/40-2. It is very simple, the 20/40 criteria can be 20/40 or 20/40 +1 but it cannot be 20/40 -2 or -3. I have been involved in 7 PDA studies of laser vision correction as principal investigator so I am very familiar with the PDA requirements. Mr. Morgan should have been disqualified from consideration based on this fact alone.

2

--------------------------------------------------------------------------------

Dr. Willis also tries to cloud the issue about what is a clinically significant abnormality and its role as an exclusion criteria. He admits that ROP is a clinically significant abnormality and goes on to say it does not contraindicate refractive surgery because "no one has a significant degree of experience in operating on patients with ROP." That is precisely the point. Mr. Morgan was told he was a "good candidate for LASIK." In fact, Mr. Morgan became a human subject for the study of LASIK in a patient with ROP. The Nevyas FDA study was designed to test their laser in normal myopic eyes. Mr. Morgan did not consent to be in a study of LASIK in patients with ROP to see what would happen. Had he been in such a study, a responsible IRB and the FDA would have had serious concerns about proceeding with such a study, particularly in both eyes of a patient until the preliminary results in at least one eye could have been evaluated. The informed consent would have been much different, as would the discussion of risks and benefits in the informed consent. When we first began investigations in laser vision correction (PRK) in 1990, the FDA required waiting 6 months between eyes and these were normal eyes. Performing Lasik in Dominic Morgan was a violation of the FDA protocol. Even if the protocol never existed, performing LASIK on Dominic Morgan was a serious breach of the ophthalmic community standard of care. Dr. Willis also states that it is not uncommon for Lasik patients to have continued improvements with time. Although that may be true to a minor degree with some patients, in my experience with thousands of patients, a decrease in best corrected vision to the 20/70 to 20/80 level 4 to 5 days after surgery, even in a normal eye, should have been a red flag to not proceed with surgery on the other eye until the outcome was more clearly established. In the vast majority of patients, a 3 to 4 line loss in the best-corrected vision several days after surgery in the absence of obvious causes such as dry eye, striae, or inflammation, is a serious cause for concern and surgery on the second eye should have been deferred. Mr. Morgan was not informed that surgery on his dominant eye should be deferred until the result in his left eye was well established. In fact, he was misinformed that the initial loss of vision in his left eye was temporary and that it was appropriate to proceed with surgery in his second eye. This represents an additional lack of informed consent and an additional failure to meet the proper standard of care. In summary, the reports by Dr. Orlin and Dr. Willis do not change my opinions about the deviations from the standard of care by Dr. Nevyas and the damages to Mr. Morgan, which resulted from his Lasik surgery. Sincerely, James J. Salz, M. D. signature on original scanned document Nevyas v. Morgan

3

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Beverly Hills Eye Medical Group, Inc.12561 Promontory RoadLos Angeles, Ca. 90049Phone 323 653-3800 Fax 310 472-4244DECLARATION OF JAMES J. SALZ, M.D.

I, James J. Salz, M.D. make this declaration subject to the penalties of 18 Pa.C.S.A. Sec. 4904 relating to unsworn falsification to public authorities:

1. I update my curriculum vitae and that of Dr. O'Brien: I am Chair and Dr. O'Brien is Secretary of the International Society of Refractive Surgery/American Academy of Ophthalmology Executive Committee for 2003. Dr. O'Brien and I are both well acquainted with the standards of care regarding the selection of patients for LASIK.

2. Dominic Morgan had (and still has) Retinopathy of Prematurity (ROP), a disease of the retinas caused by premature birth. In other words, Dominic had significant pre­existing retinal disease.

3. Everyone agrees Mr. Morgan's ROP was significant. Defense expert Dr. Orlin stated, "His past ophthalmic history was complicated and significant for retinopathy of prematurity." [Orlin report 2/1/02, p.l, emphasis added] Defense expert Dr. Willis stated, "ROP is a clinically-significant abnormality in the sense that it represents a pre­existing abnormality in the eye..." [Willis report 5/29/02, p. 1, emphasis added]

4. The patient information brochure distributed by defense expert Dr. Orlin to his patients warns, "Laser vision correction is not for everyone....Patients who are 21 years of age or older, and have healthy eyes which are free of retinal problems, corneal scars, and any eye disease are suitable." [Laser Vision Correction/LASIK brochure of Scheie Eye Institute, pp.1, 13, emphasis added]

5. Defendant Nevyas-Wallace claimed that she "used," " followed," and "adhered to" [Nevyas- Nevyasx deposition p. 103] her written protocol calling for exclusion of any person who had, "any clinically significant abnormality on physical or ophthalmic examination that would contraindicate outpatient refractive surgery." [Nevyas-Wallace's protocol for LASIK, Exclusion Criteria, emphasis added]

6. LASIK is elective surgery. Because it is elective, the standard of care requires a high degree of predictability of results. People who are candidates for LASIK are those with conditions for which there is adequate experience to predict (not guarantee) a good result. It is not the standard of care to say, as does defense expert Dr. Willis, "The fact that no one has a significant degree of experience in operating on patients with ROP does not suggest that it is inappropriate to perform elective surgery on these patients." [Willis report 5/29/02, p. 1] To the contrary, no one (except Nevyas-Wallace) has any experience performing LASIK on patients with ROP, so no one can predict a good result, and it is below the standard of care to perform the surgery.

--------------------------------------------------------------------------------

7. Dr. Willis' statement is incorrect and disingenuous; as I previously reported, there are no reports in the literature of anyone ever doing LASIK on a patient with ROP like Dominic. As I previously reported, I am unaware of any ophthalmic surgeon ever having done LASIK on a patient with ROP like Dominic. During the last two years as I have traveled around the country, including Philadelphia, I have asked other ophthalmic surgeons if they were aware of such a thing, or would do such a thing. The answers are uniformly no; everyone believes it is predictable that a poor result would be the likely outcome.

8. Since performing elective LASIK on virtually any significant eye or retinal abnormality or disease is below the standard of care, the ophthalmic community literature does not piecemeal list each significant eye or retinal abnormality or disease "in and of itself." The literature employs more useful generic categorical warnings.

9. As I previously reported, there are multiple reasons why performing LASIK on Mr. Morgan was below the standard of care. These included:

A) doing his dominant right eye one week after getting poor results in the left eye. I previously reported why going ahead with the right eye in the face of poor results in the left was below the standard of care.

B) violating Nevyas-Wallace's own written protocol requiring pre-operative best corrected visual acuity (BCVA) in both eyes of 20/40 or better. I previously reported that it is below the standard of care not to follow one's own protocol.

C) failing to provide a "safety net." I previously reported that the standard of care is to provide a "safety net" in case the procedure produces less than desirable results. By doing LASIK in Mr. Morgan with his significant pre-existing ROP, by violating Nevyas-Wallace's own written protocol requiring pre-operative BCVA in both eyes of 20/40 or better, and by operating when a good result could not be predicted, Nevyas-Wallace took away that safety net.

D) uncertainty how and where to center the laser ablation.

E) barotrauma (i.e. pressure trauma) during application of the suction ring or cutting of the corneal flap, causing further damaging to pre-existing damaged retinas and optic nerves.

10. At the risk of repeating what I previously reported, I address the last two items.

11. Uncertainty how and where to center the laser ablation:

a) As I previously reported, there is an argument in the literature about how and where to center the laser for doing LASIK in normal eyes. Some ophthalmic surgeons prefer to center the laser ablation over the pupil, as recommended by Guyton, Elk's and Hunter. Others prefer to center the laser ablation over the visual axis or "line of sight," as recommended by Wachler and Buzzard. Each claims that its method of centration is better. In normal eyes this argument is of little practical consequence because people with normal retinas essentially see through the pupil center. Thus, either way, the area of laser ablation ends up being virtually identical.

b) In ROP patients this literature argument would be an issue of great importance because nobody knows how or where to properly center the laser ablation.

--------------------------------------------------------------------------------

c) Unlike people with normal retinas who see through the pupil center, those with ROP see nasally to the pupil center. Because the macula is dragged temporally and has a positive angle kappa, the visual axis or "line of sight" is shifted nasally. In other words, the potential areas of laser ablation would be quite different from each other.

c) Dr. Willis tries to minimize this literature argument and important issue by writing, "Though some controversy exists as to whether centration on the pupil is appropriate, opinions generally favor centration on the visual axis." [Willis report 5/29/02, p. 2]

d) The point is that nobody knows how or where to properly center the laser ablation in patients with ROP. Nobody has adequate experience to predict a good result, and thus nobody can properly say that a ROP patient is a "good candidate for LASIK." For this reason alone, LASIK in ROP is below the standard of care:

12. Barotrauma:

a) As I previously reported, during LASIK a suction ring is placed on the eye to flatten the cornea and keep the eye from moving. The increased pressure on the eye, often 3 to 5 times normal, can damage even a normal retina or optic nerve. From the time the suction ring is put on the eye until it is removed, vision appears dim or goes black.

b) World-wide literature documents barotrauma damage during LASIK even in eyes without any pre-existing retinal or optic nerve abnormality. As examples I refer to Principles and Practice of Refractive Surgery (USA), Lasik Principles and Techniques (USA), Laser in Situ Keratomileusis-induced Optic Neuropathy (USA), Bilateral macular hemorrhage after laser in situ keratomileusis (Argentina), and Macular hemorrhage after laser in situ keratomileusis for high myopia (France).

c) Nevyas-Wallace's own Bilateral Simultaneous Lasik patient information form states that this significantly increased pressure during LASIK can damage even a normal retina.

d) Dominic had "clinically-significant... pre-existing abnormality in the eye..." [Willis report 5/29/02, p. 1] The retinas were clearly damaged with retinopathy. The maculas were dragged temporally, meaning the optic nerves were abnormally stretched, and also dragged temporally. As I previously reported, Dominic had abnormal optic nerves, which appeared to be small and hypoplastic in the pre-operative photos 4/6/98 at the Nevyas Eye Center and by my exam. The report by Dr. DeJuan at Johns Hopkins described "anomalous" optic discs..

e) Pre-existing retinal and optic nerve abnormalities make eyes more susceptible to virtually any kind of trauma, including barotrauma. The ophthalmic community literature does not piecemeal list each significant eye or retinal abnormality or disease "in and of itself," but employs more useful generic categorical warnings. Barotrauma is one of these generic categorical warnings, and is widely written about - somebody is always being punched in the eye, etc.

f) Even if there were nothing in the literature about barotrauma aggravating pre­existing retinal and optic nerve abnormalities (and there is), the point remains that nobody has adequate experience to predict a good result, and thus nobody can properly say that a ROP patient is a "good candidate for LASIK." For this reason alone, LASIK in ROP is below the standard of care.

--------------------------------------------------------------------------------

13. Because nobody could legitimately predict a good result for DM, and he was not a fit candidate for LASIK, DM was a human "guinea pig. Dated: signature on original scanned document Nevyas v. Morgan

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Beverly Hills Eye Medical Group, Inc.12561 Promontory RoadLos Angeles, Ca. 90049Phone 323 653-3800 Fax 310 472-4244

DECLARATION OF JAMES J. SALZ, M.D.

I, James J. Salz, M.D. make this declaration subject to the penalties of 18 Pa.C.S.A. Sec. 4904 relating to unsworn falsification to public authorities:

1. I update my curriculum vitae and that of Dr. O'Brien: I am Chair and Dr. O'Brien is Secretary of the International Society of Refractive Surgery/American Academy of Ophthalmology Executive Committee for 2003. Dr. O'Brien and I are both well acquainted with what is meant by "healthy" or "stable" retinas.

2. "Health" means "free from disease." "Healthy" retinas means retinas "free from disease."

3. "Stable" means "staying unchanged." "Stable" retinas means retinas "staying unchanged."

4. Defense expert Dr. Orlin distributes a brochure for patients in his office warning, "Laser vision correction is not for everyone...Patients who are 21 years of age or older, and have healthy eyes which are free of retinal problems, corneal scars, and any eye disease are suitable." [Laser Vision Correction/ LASIK brochure of Scheie Eye Institute, pp. 1,13, emphasis added] The brochure states, "This booklet... is for informational purposes only." [id, p.2]

5. Everyone agrees Dominic Morgan's Retinopathy of Prematurity (ROP) was significant. Dr. Orlin stated, "His past ophthalmic history was complicated and significant for retinopathy of prematurity." [Orlin report 2/1/02, p.l, emphasis added] Defense expert Dr. Willis stated, "ROP is a clinically-significant abnormality in the sense that it represents a pre-existing abnormality in the eye..." [Willis report 5/29/02, p. 1, emphasis added]

6. Dr. Orlin's statement, "Mr. Morgan's retinas were 'healthy' for the purposes described in the brochure" is illogical. Retinas are either healthy or they are not. Dominic's retinas were clearly not healthy "for the purposes described in the brochure" or any other purpose.

7. Dr. Orlin's statement, "The statement made in the brochure does not apply to stable retinas, such as the retinas of the plaintiff at the time he underwent LASIK..." is also illogical. It equates stable retinas with healthy retinas, and that is simply not correct. Stable retinas does not mean healthy retinas.

--------------------------------------------------------------------------------

8. While knowing if Mr. Morgan's retinas were "stable" at the time he underwent LASIK is useful, it is not the issue at hand. Whether the retinas were stable or not before LASIK, the retinas were certainly not healthy or normal before LASIK, and the real issue is would those abnormal retinas be "stable" after LASIK? They would not, and it was predictable they would not, causing Dominic's visual problems.

9. There are only so many ways I can say it: Doing LASIK in a ROP patient like Dominic is below the standard of care. Dr. Orlin is, no doubt, embarrassed that his patient brochure contradicts his position in this case, but the fact is the brochure is accurate, and Dr. Orlin is trying to avoid his own contradiction.

Dated: signature on original scanned document Nevyas v. Morgan

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Beverly Hills Eye Medical Group, Inc.12561 Promontory RoadLos Angeles, Ca. 90049Phone 323 653-3800 Fax 310 472-4244

DECLARATION OF JAMES J. SALZ, M.D.

I, James J. Salz, M.D. make this declaration subject to the penalties of 18 Pa.C.S.A. Sec. 4904 relating to unswom falsification to public authorities:

1. I update my curriculum vitae and that of Dr. O'Brien: I am Chair and Dr. O'Brien is Secretary of the International Society of Refractive Surgery/American Academy of Ophthalmology Executive Committee for 2003. Dr. O'Brien and I are both well acquainted with how medical diagnoses are made by ophthalmologists. For the most accurate diagnoses, the entire medical record should be available.

2. After LASIK, Mr. Morgan saw Nevyas-Wallace's group for almost 2 years, as well as several other ophthalmologists, seeking to correct his worsened vision. The records confirm that Dominic told Nevyas-Wallace and the other ophthalmologists what each told him, that Dominic obtained some copies of records to take from one to the other, and that sometimes the ophthalmologists wrote or telephoned each other, but no ophthalmologist had copies of all the medical records from all the other ophthalmologists,

3. The only persons to review copies of the entire medical records appear to be Dr. O'Brien (after he became an expert) and me. I am not certain what Dr, Orlin and Dr. Willis reviewed. The early post-LASIK period;

4. Nevyas-Wallace initially told Dominic that all his problems were temporary and would pass with time, first 3 to 6 months, then 6 to 12 months. Meanwhile, Nevyas-Wallace wrote in the records that there were problems in centering the laser ablation during the left eye LASIK procedure (operative note 4/23/98), with resultant temporal decentration in the left eye (medical records 4/27/98, 5/4/98), and nasal decentration in the right eye (medical record 7/6/98),

5. Three other ophthalmologists seeing Dominic after LASIK, Karen Fung, M.D. (medical record 8/3/98), John Dugan, M.D. (medical record 8/25/98), and Michael Belin, M.D. (medical record 1/25/99 told Dominic and wrote that they were concerned with LASIK causing decentration problems. After Dr. Dugan talked with Dr. Guyton (see below, on 6/19/00) he wrote both that he was uncertain, as well as writing about decentration. The later post-LASIK period;

6. Peter Laibson, M.D. wrote (letter 2/23/99): "I think it is either a retinal problem (you are familiar with his past history of regressed retinopathy of prematurity with peripheral

--------------------------------------------------------------------------------

lattice degeneration) or possibly other factors, which are not obvious on the objective examination." When deposed. Dr. Laibson would not answer all pertinent questions. Asked by defendants if LASIK was responsible for Dominic's loss of visual acuity, Dr, Laibson said, "1 can say that the LASIK surgery looked like it was done appropriately; and that as for as visual loss is concerned, I don't know how to answer that question." [deposition Laibson p.24, 25] When asked again by defendants if LASIK was responsible for Dominic's Joss of visual acuity, he said, "I don't know."[deposftion Laibson p.26J When further pressed by defendants, he questioned the accuracy of defendant's medical records: "I felt it was not likely that if he really did have 20/40 that the LASIK was responsible for the reduction in vision to 20/70." [deposition Laibson p.27, emphasis added] When plaintiffs attorney asked, "Doctor, would you consider the use of the suction cup and the increased intraocular pressure as one of the other factors that you're referring to?' he answered, "I have no comment on that."[deposition Laibson p.38]

7. Nevyas-Wallace wrote (medical record 3/8/99): ""Phone call from patient...He says Dr. Michael Belin and Dr. Pater Laibson each said the cornea looks fine and that the problem must be retinal." Thereafter Nevyas-Wallace's continued to assure Dominic that his problems would clear up with time, but what was written in Nevyas-Wallace's medical records changed,

8. Sheldon Morris, M.D. wrote (medical record 4/17/00): “Low VA [visual acuity] related to retinal problems." At deposition Dr. Morris said he did not know if the retinal problems were worsened by the LASIK procedure or independent of LASIK. [deposition Morris p. 22]

9. Herbert Nevyas wrote (medical record 4/26/99): 'Impression: Retinal problem Rule out hysteria,"

10. Paul Beer, M.D. wrote (letter 7/21/99): "The explanation that was raised by one of the previous consultants, that his refractive surgery is not aligned with the physical location of his macula, may be very reasonable."

11(A). Herbert Nevyas wrote (medical record 7/26/99): "Impression: Topography shows central ablation, and no increase (in vision) with contact lens. Therefore, problem is retinal."

(B). Nevyas-Wallace wrote (medical record 10/11/99): "Impression: Discussed in detail - that as per Drs, Laibson, O'Brien, and Belin, the cornea and topography are excellent and that slight drop in visual acuity is symptomatic with marginal acuity at the onset. Also that retinal factors including retinopatby of prematurity likely to be responsible." This implied that retinal factor other than retinopathy of prematurity were present, and Nevyas-Wallace repeated her implication [deposition Nevyas- Nevyasx p. 212]: "I discussed matters in detail and I explained to him that I agreed with Dr. Laibson and Dr. O'Brien and Dr. Bella in their assertions that both the appearance of the cornea and the cornea! topography are excellent and that slight drop in visual acuity is

--------------------------------------------------------------------------------

symptomatic and that retinal factors, including his retinopathy of prematurity, are likely to be responsible."

12. Eugene DeJuan, M.D. wrote for diagnoses: Question of optical phenomena and retinal degeneration or ischemia secondary to vacuum [cup for LASIK]. (Johns Hopkins medical record 11/29199)

13. David Fischer, M.D. wrote (letter 3/3/00): "The more insidious causes of diminished vision concern the retina which your LASIK surgeons felt were the culprit. Your fluorescein angiogram was felt to be normal as were your visual fields. The ERG showed mild retinal dysfunction, cause to be determined. During LASIK procedures a suction cup is placed on the eye causing increased intraocular pressures. Could this be a factor as a long-term optic neuropathy which may also be related to your retinopathy of prematurity? I'm afraid these are questions that I cannot answer and I'm hopeful that the doctors at Johns Hopkins can elicit these answers for you,"

14. David Guyton, M.D, saw Dominic at Johns Hopkins in June 2000. Dr. Guyton stated, "I could say from that that the refractive surgery wasn't the only thing which was decreasing his vision" [Guyton deposition p. 19] Dr, Guyton stated that the other thing which was decreasing Dominic's vision, which he deduced by a process of elimination [Guyton deposition p. 45] was barely visible cataracts (unrelated to LASIK), and suggested waiting [two yean] to see if there would be any progression. Absent progression he felt cataracts could not be part of Dominic's visual problem, (letter 6/19/00 and deposition pp. 22, 23, 38, 39).

15. The other two Johns Hopkins doctors, Eugene DeJuan, M.D. (with his fellow, Joseph Harlan, M.D.) and Terrence O'Brien, M,D., did not believe there were cataracts, but did not regard waiting as unreasonable.

16. When 1 examined Dominic 4/27/02 it was almost 2 years after Dr. Guyton and there was no progression. As I previously reported, ray opinion is that there are no cataract problems, and Dominic's problems are related to decentered laser ablation, and retinal and optic nerve damage.

17. Terrence O'Brien, M.D., having waited 2 years after Dr. Guyton, agreed with me and became a plaintiff expert.

18. Defense expert Dr. Orlin examined Dominic 1/30/02, 2 1/2 years after Dr. Guyton, and stated, ''over the past two years, these have remained minima] and non-progressive," [Orlin report 6/12/02, p. 2] and neither be nor defense expert Dr. Willis suggested any cataract problems.

Dated: signature on original scanned document Nevyas v. Morgan

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Beverly Hills Eye Medical Group, Inc.12561 Promontory RoadLos Angeles, Ca. 90049Phone 323 653-3800 Fax 310 472-4244DECLARATION OF JAMES J. SALZ, M.D.

I, James J. Salz, M.D. make this declaration subject to the penalties of 18 Pa.C.S.A. Sec. 4904 relating to unsworn falsification to public authorities:

1. I update my curriculum vitae: I recently wrote a chapter for an ophthalmology text scheduled for publication in the near future, in which I discuss the advantages of performing LASIK in each eye on separate days, and I reviewed the studies and literature on this subject.

2. Two advantages Nevyas-Wallace lists for performing LASIK hi each eye on separate days, are

(1) "The doctor can monitor the hearing process and visual recovery hi the first eye and may be able to make appropriate modifications to the treatment plan for the second eye, increasing the likelihood of a better outcome in the second eye," and

(2) 'You will be given the opportunity to determine whether the LASIK procedure has produced satisfactory visual results without loss of vision..." [Nevyas-Wallace's Bilateral Simultaneous Lasik patient information form, p.2]

3. Nevyas-Wallace misinformed Dominic, despite the initial poor result in his left eye, that he was "doing well," and recommended and performed LASIK surgery on the dominant right eye one week after the left eye.

4. Dominic thus lost the opportunity to "save" his dominant right eye.

5. As I previously reported, this was below the standard of care, and is another example of Nevyas-Wallace taking away the safety net.

Dated: signature on original scanned document Nevyas v. Morgan

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

DR. SALZ' REPORTS - SCANNED IMAGES

PAGE 1 PAGE 2 PAGE 3

PAGE 1 PAGE 2 PAGE 3 PAGE 4 PAGE 5

PAGE 1 PAGE 2 PAGE 3

PAGE 1 PAGE 2

PAGE 1 PAGE 2 PAGE 3 PAGE 4

PAGE 1 PAGE 2 PAGE 3

PAGE 1 PAGE 2 PAGE 3

 PAGE 1


Read more...
 
Nevyas' Court Depositions In My Case & Others PDF Print E-mail

Click PAGE # to open page in new window

Excerpt of my deposition in this case:

PAGE 1PAGE 2PAGE 3PAGE 4

Excerpt of deposition of Anita Nevyas-Wallace in my case:

PAGE 1PAGE 2PAGE 3PAGE 4PAGE 5PAGE 6
PAGE 7PAGE 8PAGE 9PAGE 10PAGE 11PAGE 12
PAGE 13

Excerpt of deposition Anita Nevyas-Wallace in another case:

PAGE 1PAGE 2PAGE 3PAGE 4PAGE 5PAGE 6PAGE 7
PAGE 8PAGE 9PAGE 10PAGE 11PAGE 12PAGE 13PAGE 14
PAGE 15PAGE 16PAGE 17PAGE 18PAGE 19PAGE 20PAGE 21
PAGE 22PAGE 23PAGE 24PAGE 25PAGE 26PAGE 27PAGE 28
PAGE 29PAGE 30PAGE 31PAGE 32PAGE 33PAGE 34PAGE 35
PAGE 36

Excerpt of deposition of Herbert Nevyas in my case:

PAGE 1PAGE 2PAGE 3PAGE 4PAGE 5
PAGE 6PAGE 7PAGE 8PAGE 9PAGE 10
PAGE 11

Excerpt of deposition of Herbert Nevyas in another case:

PAGE 1PAGE 2PAGE 3PAGE 4PAGE 5PAGE 6
PAGE 7PAGE 8PAGE 9PAGE 10PAGE 11PAGE 12
PAGE 13PAGE 14PAGE 15PAGE 16PAGE 17PAGE 18
PAGE 19

 
Nevyas' Threats of Lawsuit and Intimidation to Shut Down My Websites PDF Print E-mail

This section is currently being edited for content:Nevyas v. Morgan 

In April, 2000 I filed a medical malpractice lawsuit against Herbert Nevyas and his daughter Anita Nevyas-Wallace, two Philadelphia area LASIK doctors and their practice, Nevyas Eye Associates.

I found out I was not alone. At the time I started this website, there had been multiple cases of medical malpractice (including mine) filed against these doctors and their business, as listed in the Philadelphia Civil Docket Access System.

000402621 or 031100946

In response to posting this website, and including the Nevyases names, I have been sued. Through threats of lawsuit and intimidation, my website was shut down three times previously, the 2nd time after a temporary restraining order was sought, and denied (by the courts). Because of the way my medical malpractice lawsuit was handled through the courts, I believe it necessary to document this case in its entirety.

Below is a chronology of my latest litigation with the Drs. Herbert Nevyas, Anita Nevyas-Wallace, and Nevyas Eye Associates (Nevyases), Bala Cynwyd, PA (I could not name them previously due to litigation).  All of the documents are filed with the courts, and are public record:

Dates are separated to reduce page load times due to volume. Click date to view date filings in new window:

July/August 2003

I updated my website to include information obtained about Drs. Herbert Nevyas and Anita Nevyas-Wallace, and Nevyas Eye Associates.

After receiving a cease and desist letter from Nevyases attorney, I put my website back to its original state and responded with a letter of intent. In the course of a week, my website was shut down after YAHOO also received a letter. After hosting with a new company and determining the legal extent of their threat and making changes to the site, I posted new information with documents to support.

November 2003

On November 7th, the Nevyases filed a lawsuit against me for defamation, also claiming I broke an agreement with them. They were asked numerous times by my (then) attorney and also filed with the courts, to state what they felt were legally objectionable with my website. They refused, and filed an emergency petition for a Temporary Restraining Order (TRO), which was denied. On November 26th, Nevyases filed a motion for reconsideration (TRO), which was also denied.

In December, I filed an answer to a complaint, with New Matter and a Counterclaim.

November 07, 2003

Parts  2  3  4  5  6  7  8

November 17, 2003 November 26, 2003

Parts  2  3  4

December 04, 2003

Part  2

2004

After the Nevyases were denied reconsideration for TRO, they withdrew the lawsuit against me in Philadelphia Court, and filed in Federal Court. This time Nevyases tried for subject matter jurisdiction by claiming the content on my site violated the Lanham Act, and also joined my attorney for letters he wrote to the FDA on my behalf which I posted on my site.  I published those letters because they supported all of the other documents on my site, and the documents on my site supported those letters (Due to ongoing litigation, those letters cannot be published at this time). The Nevyases also attempted another restraining order, which they never got. This action was dismissed for failure to state a federal claim.

The Nevyases again brought suit against me in Philadelphia court using the same method as federal court, by joining my attorney as a defendant. The court filings listed below are by the Nevyases, and my responses:

February 10, 2004 May 20, 2004

Parts  2  3  4  5  6  7  8

July 27, 2004 November 16, 2004
November 18, 2004 November 29, 2004 November 30, 2004

Part  2

December 02, 2004
December 10, 2004

Parts  2  3  4  5

December 13, 2004 December 17, 2004

Part  2

December 28, 2004 A Part  2

December 28, 2004 B

 

2005

The case went to trial on July 26, 2005 on the claim for specific performance, and the court ruled in the Nevyas' favor. It found that the Nevyases and I had entered into an agreement whereby in exchange for the Nevyases not filing a lawsuit against me, that I would remove all defamatory statements about the Nevyases from the site and refrain from defaming them in the future. But the trial court's order went a bit further -- it forbid me from mentioning the Nevyases at all, on this, or any other website.

I believed the judge erred in his ruling, and sought the help of  Public Citizen for appeal, who also felt this decision was wrong. The ACLU helped me to obtain local counsel for my appeal.

January 11, 2005

 

January 18, 2005A Parts 2  3  4  5

January 18, 2005B Parts 2  3  4

January 21, 2005 January 27, 2005

Part  2

January 28, 2005

Part  2

January 31, 2005 February 02, 2005 February 04, 2005
February 07, 2005

Parts  2  3  4  5  6 7 8 9

February 11, 2005 February 15, 2005 February 24, 2005
March 11, 2005

 

March 14, 2005 March 18, 2005 March 21, 2005
March 25, 2005

 

April 09, 2005   Parts  2  3  4  5 

 6  7  8  9  10

April 15, 2005 Judge ruled contract
August 05, 2005 September 02, 2005 October 25, 2005 October 28, 2005

 

November 21, 2005 December 01, 2005 December 02, 2005

Parts  2  3  4  5

December 13, 2005

 

December 20, 2005

 

December 22, 2005A Parts  2  3

December 22, 2005B

2006

 

January 06, 2006

 

January 11, 2006 January 13, 2006 

Parts  2  3  4  5  6  7  8  9

January 17, 2006
January 20, 2006

 

February 07, 2006 February 22, 2006 March 01, 2006
April 25, 2006

 

May 09, 2006

Part  2

 

 

 

 

   

 

2007

 

 

 

 

   

 

 THE OPINION OF THE SUPERIOR COURT OF PENNSYLVANIA AS OF MARCH 09, 2007

 
Dr. Stephen Orlin PDF Print E-mail

Philadelphia, PA

note: Dr. Orlin was expert witness for Drs. Herbert Nevyas and Anita Nevyas-Wallace in several of lawsuits. Below are his opinions in my lawsuit and transcript of video testimony in the Wills v Nevyas lawsuit.

Read more...
 
Help from the AAO & State Medical Boards PDF Print E-mail

American Academy of Opthalmology & State Medical Boards

All documents posted throughout my website have been sent to the AAO's Ethics Committee and State Medical Boards of Pennsylvania and New Jersey.  The help received from any of them was none even though the documents clearly show deviations from standard of care, and many violations.  I strongly believe your expectations of any kind of help will be shortlived if you believe any of these agencies will help. These documents were filed with the Philadelphia Courts, and are public records.

Pages 1, 2, and 3 are the initial letter I sent to the AAO. The Nevyases attorneys deemed these defamatory, however, I believe the documentation provided (as well as the documents throughout this website) DOES support this letter.

Click the Page # to enlarge pages in new window

 

PAGE 1PAGE 2PAGE 3PAGE 4PAGE 5PAGE 6
PAGE 7PAGE 8PAGE 9PAGE 10PAGE 11PAGE 12
PAGE 13PAGE 14PAGE 15PAGE 16PAGE 17PAGE 18
PAGE 19PAGE 20PAGE 21PAGE 22PAGE 23PAGE 24
PAGE 25PAGE 26PAGE 27PAGE 28PAGE 29PAGE 30
PAGE 31PAGE 32PAGE 33PAGE 34PAGE 35PAGE 36
PAGE 37PAGE 38PAGE 39PAGE 40PAGE 41PAGE 42
PAGE 43PAGE 44PAGE 45PAGE 46PAGE 47PAGE 48
PAGE 49PAGE 50PAGE 51PAGE 52PAGE 53PAGE 54
PAGE 55PAGE 56PAGE 57PAGE 58PAGE 59PAGE 60
PAGE 61PAGE 62PAGE 63PAGE 64PAGE 65PAGE 66

I ended up cancelling the complaint with the AAO prior to the July '05 trial for several reasons, but it was apparent the AAO had already made its decision to not take action against the Nevyas'.  The same decision came from the Pennsylvania State Medical Board at the same time, whereas New Jersey's State Medical Board made its decision within 2 months. 

 
Updates PDF Print E-mail

This section of my website is being updated live due to cosmetic problems, template & load times for content, editing of content, and appearance between preview screen and actual internet viewing.

Thank you for your continued patience.